Vanguard Capital Management
DXCM icon

Vanguard Capital Management’s DexCom DXCM Stock Holding History

Vanguard Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.13B Sell
24,704,482
-505,270
-2% -$42M 0.04% 309
2026
Q2 		$1.7B Buy
25,209,752
+188,791
+0.8% +$12.6M 0.04% 367
2026
Q1 		$1.57B Buy
+25,020,961
New +$1.74B 0.04% 373

Other funds holding DXCM

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Vanguard Capital Management's DXCM Position: Q3 2026 in Review

Vanguard Capital Management reduced its DexCom (DXCM) stake by 2% in Q3 2026, selling an estimated $42M and leaving 24,704,482 shares worth $2.13B. The position accounts for 0.04% of the portfolio, ranked #309.

Vanguard Capital Management first reported a position in DXCM in Q1 2026 and has held it in 3 quarters since. 863 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Vanguard Capital Management held 24,704,482 shares of DexCom worth $2.13B as of Q3 2026.
  • Vanguard Capital Management sold 505,270 DexCom shares in Q3 2026, an estimated $42M.
  • DexCom made up 0.04% of Vanguard Capital Management's portfolio in Q3 2026, its #309 holding.
  • Vanguard Capital Management first reported a position in DexCom in Q1 2026 and has held it in 3 quarters since.
  • 863 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.